학술논문
Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: An open-label, randomised phase 3 trial
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, April 2011, 12(4):333-343)
Subject
Language
English
ISSN
14702045